Olema Pharmaceuticals Financials - Benzinga

Olema Pharmaceuticals inc

OLMANASDAQ

Trade with Public

Trade with Public

$10.75

0.020.19%

At close: Sep 4, 5:00 PM EST

$10.86

0.111.02%

After Hours: 4:12 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Olema Pharmaceuticals Financials

Olema Pharmaceuticals (OLMA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027

Olema Pharmaceuticals shares fall after completing OPERA-01 Phase 3 enrollment, with top-line data now expected in Q1 2027.

Vandana Singh

PRO
Olema Pharmaceuticals Q2 EPS $(0.61) Misses $(0.55) Estimate

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.55) by 10.91 percent. This is a 19.61 percent decrease over losses of $(0.51) per

Benzinga Newsdesk

PRO
Olema Pharmaceuticals Q1 EPS $(0.52) Beats $(0.53) Estimate

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.53) by 1.89 percent. This is a 44.44 percent decrease over losses of $(0.36) per share

Benzinga Newsdesk

PRO
Olema Pharmaceuticals Q4 EPS $(0.50) Beats $(0.53) Estimate

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.53) by 6.19 percent. This is a 1.96 percent increase over losses of $(0.51) per share

Benzinga Newsdesk

Nasdaq Down 1%; Medtronic Earnings Top Views

Avi Kapoor

Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings

Avi Kapoor